Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

Findings from a phase 1 trial demonstrate that silmitasertib shows potential for the treatment of patients with advanced basal cell carcinoma.

In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade ... involved in the regulation of immune cells signaling pathways that promote tumorigenesis by attenuating ...

Several lines of evidence link metabolic dysregulation to late-life neurodegenerative diseases. The altered glucose ...